Overview

The purpose of this study is to estimate the prevalence, demographic, and clinical characteristics of PKD1/2 gene variant groups in the ADPKD population.

Principal investigator

Lama Noureddine
Internal Medicine

Eligibility criteria

Key Inclusion Criteria:
*  Estimated glomerular filtration rate (eGFR) greater than or equal to (≥) 30 milliliter per minute (mL/min)/1.73 m\^2
*  Willing and able to comply with scheduled visits and other study procedures
*  A pre-existing diagnosis of ADPKD as defined in the protocol

Key Exclusion Criteria:
*  History of kidney disease other than ADPKD that in the opinion of the investigator would independently impact the natural history of ADPKD
*  History of solid organ or bone marrow transplantation or nephrectomy
*  Ongoing renal replacement therapy or planning to start renal replacement therapy less than or equal to (≤)12 months from the Genotyping Visit in Part A Other protocol defined Inclusion/Exclusion criteria will apply.
Show more

Participate in this trial

Are you interested in enrolling in this study? Learn more here.

I'm Interested In Participating

For Referring Providers

Do you have a patient you think would be a good candidate for this trial? Learn more about enrolling your patient.

Contact the study coordinator

Tamara Lowe
Enroll your patient